Jon M Appel

Summary

Publications

  1. doi request reprint Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer
    Jon M Appel
    Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark
    J Am Soc Echocardiogr 24:200-6. 2011
  2. doi request reprint Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer
    Jon M Appel
    Department of Cardiology, Herlev Hospital, Copenhagen, Denmark
    Acta Oncol 51:1054-61. 2012
  3. doi request reprint Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer
    Jon M Appel
    Department of Cardiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark
    Int J Cardiovasc Imaging 26:217-23. 2010
  4. doi request reprint Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failure
    Jon M Appel
    Departments of CardiologyThoracic Surgery Thoracic Anesthesiology Oncology, Rigshopitalet, Copenhagen, Denmark
    Congest Heart Fail 18:291-4. 2012

Detail Information

Publications4

  1. doi request reprint Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer
    Jon M Appel
    Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark
    J Am Soc Echocardiogr 24:200-6. 2011
    ..The aim of this study was to examine if short-term changes in cardiac function can be detected even after low-dose adjuvant epirubicin therapy for breast cancer when using Doppler tissue imaging of longitudinal left ventricular function...
  2. doi request reprint Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer
    Jon M Appel
    Department of Cardiology, Herlev Hospital, Copenhagen, Denmark
    Acta Oncol 51:1054-61. 2012
    ..We aimed to examine whether heart failure or impairment could be demonstrated several years after low-dose epirubicin-based adjuvant treatment...
  3. doi request reprint Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer
    Jon M Appel
    Department of Cardiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark
    Int J Cardiovasc Imaging 26:217-23. 2010
    ..Epirubicin induces considerable decrease in LVEF and a high risk of CHF. The risk of CHF is significantly higher if LVEF is reduced after ET. Diastolic MUGA-variables seem to add little information to conventional measurements of LVEF...
  4. doi request reprint Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failure
    Jon M Appel
    Departments of CardiologyThoracic Surgery Thoracic Anesthesiology Oncology, Rigshopitalet, Copenhagen, Denmark
    Congest Heart Fail 18:291-4. 2012
    ..Heart transplantation is often contraindicated in the first years after treatment for cancers, and LVAD as "bridge to recovery" may be warranted in similar patients...